Roche to Buy US Biotech Firm Seragon for up to $1.7 Billion

03.07.2014 - Swiss-based Roche Holding AG plans to pay up to $1.73 billion to buy Seragon Pharmaceuticals, a privately-held US biotech company that researches breast cancer treatments. Roche...